Bioinformatics Pharma Companies Pharmaceutical Companies Small Molecule 
Elrig
APRIL 29, 2024
Harini Srinivasan is a Principal Scientific Associate at Serna Bio with over 10 years of research experience in academic institutions, health care organizations and pharmaceutical companies. There, I supported AI-enabled DD efforts in their small molecule portfolio. big pharma or startups/spin off? What pro/cons?
Drug Discovery World
NOVEMBER 15, 2022
If a pharmaceutical company is racing to identify a new vaccine, for instance, then waiting for three weeks to receive DNA sequences each time can slow down the development process compared to competitors who might have faster timelines.” . “We Cell-free systems for drug design and manufacturing .
Expert insights. Personalized for you.
59 
Let's personalize your content